Susceptibility of Legionella pneumophila Isolated from Air Conditioners to Various Types of Antibiotics in Khartoum State, Sudan
The aim of this study was to evaluate the susceptibility of Legionella pneumophila isolates obtained from water samples of evaporative coolers conditioners in Khartoum State to various types of antibiotics. The number of isolated Legionella was 222 (42.3%) from a total of 525 samples. The samples were analyzed by conventional methods as well as a Real Time-PCR. Twenty isolates were subjected to disc diffusion test method. Legionella pneumophila isolates were found to be susceptible to the following antibiotics: ciprofloxacin (100%), azithromycin (85%), erythromycin (65%) and tetracycline (50%). Legionella pneumophila was resistant to Amoxicillin / clavulanic acid. Cephalexin, cefotaxim and vancomycin showed only15% sensitivity. From this study it could be concluded that Legionella pneumophila was more susceptible to ciprofloxacin followed by azithromycin than the other tested antibiotics.
Abu Khweek, A., Fernandez Da´vila, N. S., Caution, K., Akhter A., Abdulrahman, B. A., Tazi, M., Hassan, H., Novotny, L. A., Bakaletz, L.O. and Amer, A. O (2013). Biofilm-derived Legionella pneumophila evades the innate immune response in macrophages. Cellular Infect Microbiol, 3.18–26.
Barrow, G. I .and Feltham, R. K. A. (2003). Cowan and Steel᾽s Manual for the identification of the Medical Bacteria, 3rd "edition. Cambridge University Press, Cambridge, U. K.
Bruin, J.P., Diederen, B.M.W., Ijzerman, E.P., Den Boer, J.W., Mouton J.W(2013).Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophilasero group 1 isolates. DiagnMicrobiol Infect Dis
Cheesbrough, M (2000). District Laboratory Practice in Tropical Countries, Part2 Second Edition, Cambridge university press.
Cianciotto, N. P (2001). Pathogenicity of Legionellapneumophila. Int. J. Med. Microbiol. 291 (5).331–343.
Dedicoat, M., Venkatesan,P(1999).The treatment of Legionnaires’ disease. J Antimicrob. Chemother, 43(6): 747–752.
Dowling, J. N., McDevitt, D. A. and Pasculle, A. W (1985). Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and, Legionella pneumophila. Antimicrob Agents Chemother 27 (2).272–274.
Edelstein, P.H., Cianciotto, N.P. (2010). Legionella. In: Mandell GL, Bennett JE,
Dolin R, eds, Mandell, Douglas, and Bennett's Principles and Practice of
Infectious Diseases. Philadelphia: Elsevier Churchill Livingstone, 2969-84.
Elsanousi, R. M. A, Elsanousi, S. M. (2017). Detection of Legionella pneumophila from Evaporative Coolers Air Conditioners in Khartoum State, American Journal of Microbiological Research, Vol. 5, No. 6, 138-141.
Erdogan, H., Can, F., Demirbilek, M., Timurkaynak,F., Arslan, H (2010). In vitro of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey. Environ Monit Assess, 171(1–4): 487–491.
Fabbi. M., Pastoris. M. C., Scanzani. E., Magnino. S., Matteo. L. D( 1998). Epidemiological and Environmental Investigations of Legionella pneumophila Infection in Cattle and Case Report of Fatal Pneumonia in a Calf. Journal of clinical microbiology, 36(7) 1942–1947. Fraser, D. W., Tsai, T. R., Orenstein, W., Parkin, W., E., Beecham, H. J., Sharrar, R. G., Harris, J., Mallison, G.F., Martin, S. M., McDade, J. E., Shepard, C.C. and Brachman, P.S (1977). Legionnaires' disease description of an epidemic of pneumonia. N. Engl. J. med. 297(22). 1189- 1197.
Horwitz, M. A (1993).Toward an understanding of host and bacterial molecules mediating pathogenesis. (current status and emerging perspectives), Microbiol, 55– 62.
Jawetz, E., Melnick, J. L. and Adelberg’s, E.A(2013).Medical Microbiology. 26thedition McGraw-Hill Companies press, U. K.
Nguyen, T. M., Ilef, D., Jarraud, S.,Rouil,R.,Campese,c., Che, D. Haeghebaert, S. Ganiayre, F., Marcel, F., Etienne, J. , and Desenclos, J. C (2006). A community-wide outbreak of Legionnaires disease linked to industrial cooling towers – how can far contaminated aerosols spread? J. Infect Dis 193(1).102–111.
Onody, C., Bernard-Matsiota, P., Naściel, C (1997). Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila. J. Antimicrob Chemother 39(6): 815–816.
Pedro-Botet, M. L. and Yu, V. L (2009). Treatment strategies for Legionella infection. Expert. Opin. Pharma.10 (7). 1109-1121.
Rabih W M, Kafi SK, Eldowma E Y, Khalid A Abdelhalim (2014).The Rate of Detection of Legionella pneumophila IgG Antibodies among Patients with Chest Infection in Major Hospitals in Khartoum State, Sudan. American Journal of Research Communication, 2(9) 185 -191.
Roig, J. and Rell,J (2003). Legionnaires’ disease. A rational approach to therapy. J. Antimicrob. Chemother. 51(5).1119-1129.
Stout, J. E. and Yu, V. L(1997). Legionellosis."N Engl J Med 337 (10). 682-687.
World Health Organization (1990). Epidemiology, prevention and control of legionellosis. Memorandum from a WHO meeting. Bulletin of the World Health Organization, 68(2).155–164.
World Health Organization (2007). Legionella and the prevention of legionellosis. Switzerland: WHO Press.
Yu, V.L, Plouffe. J. F., Pastoris. M. C., Stout, J.E., Schousboe, M., Widmer,A., Summersgill, J., File, T., Heath,C.M., D. Paterson, D. L. and Chereshsky, A (2002). “Distribution of Legionella species and sero groups isolated by culture in patients with sporadic community- Acquired legionellosis. An international collaborative survey,” J. Infect.Dis.186 (1).127–128.
- There are currently no refbacks.
U. of K. J. Vet. Med. Anim. Prod.